dr. janet woodcock for joining us. she is at the fda center for drug evaluation and research. and their mission, that agency's mission, is to make certain that the public has access to safe and effective drugs. earlier this summer, kansans and people, families with allergies, children had allergies, they had allergies, were faced with the dramatic increase in the cost of the epinephrine injectors or epipens. and in my view, that raises issues for us as appropriators for the food and drug administration in this sense -- the food and drug administration does not have jurisdiction over cost or price of drugs. they're be a regulator in that regard. but their role is to make certain that drugs are efficient efficacy, and as well as safety. part of that process of safety and efficacy is bringing generics to market, and i think it would be useful for our subcommittee to hear to hear th developments fda, in regard to that process. i think all of us have an interest in making certain drugs that are effective and useful are made available to consumers across the country at prices that a